by Stanford University Stanford virologist Jeffrey Glenn did not set out to tackle cancer. For years, he and his lab have worked to develop new ways of battling viruses like the ones that cause hepatitis delta and the common cold—but the lessons they’ve learned fighting viruses has led to a new kind of drug that...
Tag: <span>Cancer Drug</span>
Post
Endometriosis could be treated with cancer drug, study suggests
UNIVERSITY OF EDINBURGH The painful symptoms of endometriosis – a chronic condition which affects millions of women – could potentially be reduced with a drug that had previously been investigated as a cancer treatment. Researchers found that using dichloroacetate to treat the cells of women with endometriosis lowered the production of lactate – a potentially...
Post
Red Light Activated Cancer Drug Improves Treatment in Mice
OCTOBER 7TH, 2019 SIAVASH PARKHIDEH MEDICINE, ONCOLOGY Researchers from the City University of Hong Kong have developed a new, controllable cancer drug called phorbiplatin that only becomes active and potent after red light stimulation. Their work demonstrates that in the dark the cancer drug does not have substantial toxicity, but the drug is able to...
Post
New evolution-busting drug overcomes resistance in aggressive breast cancers
INSTITUTE OF CANCER RESEARCH A new type of drug that blocks one of cancer’s key evolutionary escape routes from chemotherapy could be used to treat aggressive breast cancers, a new study has shown. Scientists at The Institute of Cancer Research, London, found that the drug could reinvigorate the response to chemotherapy in cancers that had...
Post
A New Cancer Drug, Thanks to a New Approach
Posted Today The newest cancer treatment on the market owes something to one of the earliest advocates for modern science. In his work Novum Organum, which is widely credited with introducing the scientific method, Francis Bacon wrote of the need for creative thinking to achieve anything new, saying that it would be a mistake, “to expect that things which...
Post
Velcro-like proteins keep cancer drugs inside the cancer
Michael Irving There are several techniques used to kill cancer, such as chemotherapy and radiotherapy, but the really tricky part is doing so without harming the rest of the body. Cytokines are small proteins that could play a part in immunotherapy, but they’ve so far not been approved for use, given their toxicity to healthy...
Post
Rising drug prices widen gap between have, have-not patients
For Bridgett Snelten, changing her health insurance meant enduring wild blood sugar swings, bouts of vomiting and weight gain. The Sandy, Utah mother of two young girls has diabetes and has had to change health insurance plans three years in a row. Twice, new insurers wouldn’t cover Trulicity, a once-a-week injected diabetes medicine she’d been...
Post
Cancer drug earns FDA nod after decades
Duncan Hunter chokes up a little when it is suggested that work he began at Western three decades ago will now, finally, be applied to saving hundreds of lives. “It’s a good thing,” said the Chemistry professor emeritus after a long pause. “It took 30 years and had its ups and downs. So, yes, it’s...
Post
Scientists develop novel drug that could potentially treat liver cancer more effectively
A research team led by scientists from the Cancer Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has developed a novel peptide drug called FFW that could potentially stop the development of hepatocellular carcinoma (HCC), or primary liver cancer. This landmark discovery opens the door for more effective treatment of liver cancer with...
Post
FDA grants first approval for CA drug under new pilot programs
(HealthDay)—The U.S. Food and Drug Administration has approved Ribociclib (Kisqali) in combination with an aromatase inhibitor (AI) as an initial endocrine-based therapy for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. Ribociclib has also been approved with fulvestrant as initial...